TCE双抗，作为一种创新的免疫疗法，其原理是通过激活T细胞来攻击肿瘤细胞或自免疾病相关细胞。与传统的免疫疗法相比，TCE双抗具有更高的便利性和成本优势。尤其在面对如CAR-T这类“百万元一针”的疗法时，TCE双抗的性价比更加凸显。

12月16日，火热的TCE再次成为医药行业重点押注的赛道。一天之内，Candid Therapeutics接连宣布分别与诺纳生物、岸迈生物、Ab Studio三家企业达成了TCE合作。已知合作总额高达13.2亿美元（约合人民币96.14亿元）。

On Tuesday morning, local officials gathered at IBM's former campus area in Endicott for the beginning of the site's ...

The U.S. EPA recently announced that it released new risk management rules under the Toxic Substances Control Act (TSCA) for TCE and PCE. 1 Manufacturers and other industrial clients need to be ...

最近，成立仅3个月的美国“黑马级”创新药公司Candid Therapeutics接连官宣3项有关TCE产品的交易，披露金额超过13亿美元。 算上今年9月时收购的两家TCE概念创新药企业 ，Candid 已经密集完成了5起TCE产品的合作，且 ...

The rules follow risk evaluations determining that both PCE and TCE present an “unreasonable risk of injury to human health or the environment” per TSCA section 6(b). The final rules ban most ...

Candid是一家总部位于美国圣地亚哥的临床阶段生物技术公司，致力于成为自身免疫性疾病领域TCE疗法开发的领导者。该公司资产分别收购于多家新药newco，分子由中国新药企业授权。 2024年12月18日，诺纳生物宣布与Candid ...

or TCE, pyrene and diesel range organics. At Charles D. Owen Park along the Swannanoa River in Black Mountain, sediment ...

trichloroethylene (TCE) and per- and polyfluoroalkyl substances (PFAS), that may have been released as well as undertake response activities to address any levels that exceed state criteria ...

The lawsuit says long-term exposure to 1,4-Dioxane can cause kidney and liver damage. The reported history of Endicott’s ...

Tsakos Energy Navigation appears undervalued, trading down 45% from its peak, with a low P/E ratio. Click here to find out ...

截至目前，2024年美国FDA药品评价与研究中心（CDER）共批准了50款新药，其中包括34款新分子实体和16款生物制品。新分子实体中，小分子居多，占比约达91%（31款），其余包括核酸与多肽类药物；生物制品中，81%为抗体类（10款单抗、3款双抗） ...